Protagen Successfully Closes New Financing Round
News Dec 16, 2014
PROTAGEN AG today announced the closing of a new financing round. In this round, QIAGEN N.V., joins existing investors MIG Fonds, Munich, NRW.BANK, Düsseldorf, and Protagen Management.
This is the first closing of a financing round with a total volume of € 10 Mio. The second closing with additional new investors is planned for the third quarter of 2015.
This latest financing round demonstrates the confidence of new and existing investors in Protagen, based upon reaching significant milestones, such as the Pharma collaboration with Pfizer Inc. and the mid 2014 launch of the first research use ADx Multilisa® SSc assay.
“The successful first closing of this round marks a significant milestone in our development and growth,” said Dr. Stefan Müllner, CEO, Protagen AG. “The financial investment will enable Protagen to complete and commercialize its current IVD development programs in Rheumatoid Arthritis, Systemic Lupus, and Systemic Sclerosis. In addition, it will strengthen our position for furthering our partnerships with Pharma and Biotech companies in one of the most attractive drug development areas.”
Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass SpecNews
Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.
Automated Robotic Device Enables Faster Blood TestingNews
Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients.READ MORE
New Method to Quickly and Accurately Detect InfectionsNews
A new study by UTSA researchers describes a method that could show quickly and accurately whether a person has been infected with harmful bacteria or other pathogens.READ MORE